Profile
Alborz Yazdi is the founder.
He founded Exavir Therapeutics in 2020 and currently holds the title of President.
Mr. Yazdi also has former job experience.
From 2020 to 2022, he worked as an Analyst at Passaic Capital Management LLC.
Prior to that, from 2019 to 2020, he was an Associate at Bain Capital Life Sciences LP.
Mr. Yazdi's education includes an undergraduate degree from Yale University.
Alborz Yazdi active positions
| Companies | Position | Start |
|---|---|---|
Exavir Therapeutics
Exavir Therapeutics Miscellaneous Commercial ServicesCommercial Services Engages in developing medicines for HIV and other viral infections | Founder | 2019-12-31 |
Former positions of Alborz Yazdi
| Companies | Position | End |
|---|---|---|
Passaic Capital Management LLC
Passaic Capital Management LLC Investment ManagersFinance Passaic Capital manages a long/short equity portfolio focused on healthcare industry. | Analyst-Equity | 2022-01-31 |
Bain Capital Life Sciences LP
Bain Capital Life Sciences LP Investment ManagersFinance Bain Capital Life Sciences invests in public and private companies located across the globe. The firm focuses on biopharmaceutical, specialty pharmaceuticals, medical device, diagnostic and life science technology sectors. It provides financing for buyout and growth stage capital requirements with an investment size of USD 25 - 100 million. | Private Equity Analyst | 2020-09-30 |
Training of Alborz Yazdi
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Yale University
Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Passaic Capital Management LLC
Passaic Capital Management LLC Investment ManagersFinance Passaic Capital manages a long/short equity portfolio focused on healthcare industry. | Finance |
Bain Capital Life Sciences LP
Bain Capital Life Sciences LP Investment ManagersFinance Bain Capital Life Sciences invests in public and private companies located across the globe. The firm focuses on biopharmaceutical, specialty pharmaceuticals, medical device, diagnostic and life science technology sectors. It provides financing for buyout and growth stage capital requirements with an investment size of USD 25 - 100 million. | Finance |
Exavir Therapeutics
Exavir Therapeutics Miscellaneous Commercial ServicesCommercial Services Engages in developing medicines for HIV and other viral infections | Commercial Services |
- Stock Market
- Insiders
- Alborz Yazdi
















